Literature DB >> 26022539

Placebo analgesia enhances descending pain-related effective connectivity: a dynamic causal modeling study of endogenous pain modulation.

Landrew S Sevel1, Jason G Craggs2, Donald D Price3, Roland Staud4, Michael E Robinson5.   

Abstract

UNLABELLED: The use of placebo to reduce pain is well documented; however, knowledge of the neural mechanisms underlying placebo analgesia remains incomplete. This study used functional magnetic resonance imaging data from 30 healthy individuals and dynamic causal modeling to investigate changes in effective connectivity associated with the placebo analgesic response. Before scanning, participants were conditioned to expect less thermal pain at 2 of 4 sites on their feet. Visual analog scale pain ratings revealed a significant but small difference between the baseline and placebo sites (mean difference = 6.63, t(29) = 3.91, P ≤ .001, d = .97), confirming an analgesic effect. However, no significant differences in the magnitude of brain activation between conditions were observed via traditional random effects general linear modeling. Dynamic causal modeling was then used to investigate changes in effective connectivity during placebo analgesia. The results indicate that during placebo analgesia but not baseline condition, couplings between brain regions, including those involved in cognitive processes (eg, attention, expectation, evaluation), were significantly enhanced. Specifically, a significantly consistent decrease in the dorsolateral prefrontal cortex → periaqueductal gray coupling was found. These findings highlight the differences between pain processing and modulation at the network level. Moreover, our results suggest that small placebo effects may be better characterized via changes in the temporal dynamics among pain modulatory regions than only via changes in the magnitude of blood oxygenation level dependent activation. Further application of nuanced analytical approaches that are sensitive to temporal dynamics of pain-related processes such as dynamic causal modeling are necessary to better understand the neural mechanisms underlying pain processing in patient populations. PERSPECTIVE: Changes in effective connectivity among pain-related brain regions may be more sensitive detectors of the neural representation of small placebo effects than are changes in the magnitude of brain activation. Knowledge of these mechanisms highlights the importance of integrated neural networks in the understanding of pain modulation.
Copyright © 2015 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Placebo; dynamic causal modeling; effective connectivity; functional magnetic resonance imaging; pain modulation

Mesh:

Substances:

Year:  2015        PMID: 26022539      PMCID: PMC4522336          DOI: 10.1016/j.jpain.2015.05.001

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  40 in total

Review 1.  Mechanisms of analgesia produced by hypnosis and placebo suggestions.

Authors:  D D Price; J J Barrell
Journal:  Prog Brain Res       Date:  2000       Impact factor: 2.453

2.  Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network.

Authors:  U Bingel; J Lorenz; E Schoell; C Weiller; C Büchel
Journal:  Pain       Date:  2005-12-20       Impact factor: 6.961

Review 3.  From nociception to pain perception: imaging the spinal and supraspinal pathways.

Authors:  Jonathan Brooks; Irene Tracey
Journal:  J Anat       Date:  2005-07       Impact factor: 2.610

4.  Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging.

Authors:  Jian Kong; Randy L Gollub; Ilana S Rosman; J Megan Webb; Mark G Vangel; Irving Kirsch; Ted J Kaptchuk
Journal:  J Neurosci       Date:  2006-01-11       Impact factor: 6.167

5.  Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients.

Authors:  Donald D Price; Jason Craggs; G Nicholas Verne; William M Perlstein; Michael E Robinson
Journal:  Pain       Date:  2006-09-08       Impact factor: 6.961

Review 6.  Placebo analgesia: friend or foe?

Authors:  Donald D Price; Roger B Fillingim; Michael E Robinson
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.592

7.  Interhemispheric integration of visual processing during task-driven lateralization.

Authors:  Klaas E Stephan; John C Marshall; Will D Penny; Karl J Friston; Gereon R Fink
Journal:  J Neurosci       Date:  2007-03-28       Impact factor: 6.167

8.  Hemispheric lateralization of somatosensory processing.

Authors:  R C Coghill; I Gilron; M J Iadarola
Journal:  J Neurophysiol       Date:  2001-06       Impact factor: 2.714

9.  Right-lateralized pain processing in the human cortex: an FMRI study.

Authors:  Laura L Symonds; Nakia S Gordon; Jonathan C Bixby; Margaret M Mande
Journal:  J Neurophysiol       Date:  2006-03-22       Impact factor: 2.714

10.  Functional brain interactions that serve cognitive-affective processing during pain and placebo analgesia.

Authors:  Jason G Craggs; Donald D Price; G Nicholas Verne; William M Perlstein; Michael M Robinson
Journal:  Neuroimage       Date:  2007-08-16       Impact factor: 6.556

View more
  12 in total

1.  Interhemispheric Dorsolateral Prefrontal Cortex Connectivity is Associated with Individual Differences in Pain Sensitivity in Healthy Controls.

Authors:  Landrew S Sevel; Janelle E Letzen; Roland Staud; Michael E Robinson
Journal:  Brain Connect       Date:  2016-03-30

Review 2.  Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons.

Authors:  Scott M Schafer; Stephan Geuter; Tor D Wager
Journal:  Prog Neurobiol       Date:  2017-11-03       Impact factor: 11.685

Review 3.  Applications of dynamic functional connectivity to pain and its modulation.

Authors:  Elizabeth A Necka; In-Seon Lee; Aaron Kucyi; Joshua C Cheng; Qingbao Yu; Lauren Y Atlas
Journal:  Pain Rep       Date:  2019-08-07

4.  Fibromyalgia: Shining a light on fibromyalgia treatment.

Authors:  Robert Bennett
Journal:  Nat Rev Rheumatol       Date:  2016-09-15       Impact factor: 20.543

5.  Brain Stimulation Differentially Modulates Nociception and Inflammation in Aversive and Non-aversive Behavioral Conditions.

Authors:  G S Bassi; A Kanashiro; G J Rodrigues; F Q Cunha; N C Coimbra; L Ulloa
Journal:  Neuroscience       Date:  2018-05-18       Impact factor: 3.590

Review 6.  What do monoamines do in pain modulation?

Authors:  Kirsty Bannister; Anthony H Dickenson
Journal:  Curr Opin Support Palliat Care       Date:  2016-06       Impact factor: 2.302

7.  Brainstem Mechanisms of Pain Modulation: A within-Subjects 7T fMRI Study of Placebo Analgesic and Nocebo Hyperalgesic Responses.

Authors:  Lewis S Crawford; Emily P Mills; Theo Hanson; Paul M Macey; Rebecca Glarin; Vaughan G Macefield; Kevin A Keay; Luke A Henderson
Journal:  J Neurosci       Date:  2021-10-25       Impact factor: 6.709

Review 8.  Bridging the Translational Divide in Pain Research: Biological, Psychological and Social Considerations.

Authors:  Chulmin Cho; Harashdeep K Deol; Loren J Martin
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

9.  Clinical Studies of Biofield Therapies: Summary, Methodological Challenges, and Recommendations.

Authors:  Shamini Jain; Richard Hammerschlag; Paul Mills; Lorenzo Cohen; Richard Krieger; Cassandra Vieten; Susan Lutgendorf
Journal:  Glob Adv Health Med       Date:  2015-11-01

10.  Unique aspects of clinical trials of invasive therapies for chronic pain.

Authors:  Steven P Cohen; Mark Wallace; Richard L Rauck; Brett R Stacey
Journal:  Pain Rep       Date:  2018-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.